Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Demoly

Showing results (31-40 of 367) with videos related to

Pageof 37
Sort By:
Immunology and Allergy Clinics of North America|July 10, 2004
Classification and epidemiology of hypersensitivity drug reactionsPascal Demoly, Dominique Hillaire-Buys
Allergy and Asthma Proceedings|July 12, 2022
Integrating the evidence in allergen immunotherapy: Why real-world data should be important for the practicing clinician?Moises A Calderon, Pascal Demoly
Expert Review of Clinical Immunology|September 12, 2018
How can the World Health Organization's International Classification of Diseases (ICD)-11 change the clinical management of anaphylaxis?Luciana K Tanno, Pascal Demoly,
Current Opinion in Allergy and Clinical Immunology|February 8, 2019
Are outcome measures in allergic diseases relevant for the WHO's International Classification of Diseases in allergology?Luciana Kase Tanno, Pascal Demoly,
Current Opinion in Allergy and Clinical Immunology|June 30, 2005
Epidemiology of hypersensitivity drug reactionsEva Rebelo Gomes, Pascal Demoly
Immunology and Allergy Clinics of North America|July 15, 2014
Drug allergy diagnosisAnca M Chiriac, Pascal Demoly
Current Opinion in Allergy and Clinical Immunology|June 27, 2013
Multiple drug hypersensitivity syndromeAnca M Chiriac, Pascal Demoly
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|November 26, 2022
Food allergy in the World Health Organization's International Classification of Diseases (ICD)-11Luciana Kase Tanno, Pascal Demoly
Expert Review of Clinical Pharmacology|February 4, 2016
Effectiveness of allergic rhinitis treatments in real-life with a focus on MP-AzeFluLudger Klimek, Pascal Demoly, David Price
Expert Review of Respiratory Medicine|March 6, 2020
Allergen immunotherapy: what is the added value of real-world evidence from retrospective claims database studies?Philippe Devillier, Pascal Demoly, Mathieu Molimard
Pageof 37

Showing results (31-40 of 367) with videos related to

Sort By:
Pageof 37
Immunology and Allergy Clinics of North America|July 10, 2004
Classification and epidemiology of hypersensitivity drug reactionsPascal Demoly, Dominique Hillaire-Buys
Allergy and Asthma Proceedings|July 12, 2022
Integrating the evidence in allergen immunotherapy: Why real-world data should be important for the practicing clinician?Moises A Calderon, Pascal Demoly
Expert Review of Clinical Immunology|September 12, 2018
How can the World Health Organization's International Classification of Diseases (ICD)-11 change the clinical management of anaphylaxis?Luciana K Tanno, Pascal Demoly,
Current Opinion in Allergy and Clinical Immunology|February 8, 2019
Are outcome measures in allergic diseases relevant for the WHO's International Classification of Diseases in allergology?Luciana Kase Tanno, Pascal Demoly,
Current Opinion in Allergy and Clinical Immunology|June 30, 2005
Epidemiology of hypersensitivity drug reactionsEva Rebelo Gomes, Pascal Demoly
Immunology and Allergy Clinics of North America|July 15, 2014
Drug allergy diagnosisAnca M Chiriac, Pascal Demoly
Current Opinion in Allergy and Clinical Immunology|June 27, 2013
Multiple drug hypersensitivity syndromeAnca M Chiriac, Pascal Demoly
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|November 26, 2022
Food allergy in the World Health Organization's International Classification of Diseases (ICD)-11Luciana Kase Tanno, Pascal Demoly
Expert Review of Clinical Pharmacology|February 4, 2016
Effectiveness of allergic rhinitis treatments in real-life with a focus on MP-AzeFluLudger Klimek, Pascal Demoly, David Price
Expert Review of Respiratory Medicine|March 6, 2020
Allergen immunotherapy: what is the added value of real-world evidence from retrospective claims database studies?Philippe Devillier, Pascal Demoly, Mathieu Molimard
Pageof 37